Camurus AB (publ) (STO: CAMX)
714.50
+10.50 (1.49%)
Aug 30, 2024, 5:29 PM CET
Camurus AB Revenue
Camurus AB had revenue of 444.87M SEK in the quarter ending June 30, 2024, a decrease of -34.02%. This brings the company's revenue in the last twelve months to 1.59B, up 8.57% year-over-year. In the year 2023, Camurus AB had annual revenue of 1.72B with 79.52% growth.
Revenue (ttm)
1.59B
Revenue Growth
+8.57%
P/S Ratio
25.34
Revenue / Employee
7.48M
Employees
213
Market Cap
41.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.72B | 760.51M | 79.52% |
Dec 31, 2022 | 956.34M | 355.77M | 59.24% |
Dec 31, 2021 | 600.57M | 264.57M | 78.74% |
Dec 31, 2020 | 336.00M | 230.39M | 218.16% |
Dec 31, 2019 | 105.61M | 56.28M | 114.12% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |
Vimian Group AB (publ) | 3.91B |